Sensei Biotherapeutics Inc (NASDAQ: SNSE) open the trading on Wednesday, with great promise as it jumped 23.54% to $1.26, before settling in for the price of $1.02 at the close. Taking a more long-term approach, SNSE posted a 52-week range of $0.51-$1.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -16.26%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.37%. This publicly-traded company’s shares outstanding now amounts to $25.03 million, simultaneously with a float of $16.29 million. The organization now has a market capitalization sitting at $31.59 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9861, while the 200-day Moving Average is $0.8708.
Sensei Biotherapeutics Inc (SNSE) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Sensei Biotherapeutics Inc’s current insider ownership accounts for 35.02%, in contrast to 11.02% institutional ownership. According to the most recent insider trade that took place on Sep 11 ’23, this organization’s President and CEO bought 500 shares at the rate of 0.85, making the entire transaction reach 425 in total value, affecting insider ownership by 111,311. Preceding that transaction, on Jun 01 ’23, Company’s 10% Owner sold 3,441,661 for 1.58, making the whole transaction’s value amount to 5,437,824. This particular insider is now the holder of 0 in total.
Sensei Biotherapeutics Inc (SNSE) Earnings and Revenue Records
Sensei Biotherapeutics Inc’s EPS increase for this current 12-month fiscal period is 19.37% and is forecasted to reach -1.04 in the upcoming year.
Sensei Biotherapeutics Inc (NASDAQ: SNSE) Trading Performance Indicators
Let’s observe the current performance indicators for Sensei Biotherapeutics Inc (SNSE). It’s Quick Ratio in the last reported quarter now stands at 11.92. The Stock has managed to achieve an average true range (ATR) of 0.11.
In the same vein, SNSE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.21, a figure that is expected to reach -0.27 in the next quarter, and analysts are predicting that it will be -1.04 at the market close of one year from today.
Technical Analysis of Sensei Biotherapeutics Inc (SNSE)
[Sensei Biotherapeutics Inc, SNSE] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 69.27% While, its Average True Range was 0.1186.
Raw Stochastic average of Sensei Biotherapeutics Inc (SNSE) in the period of the previous 100 days is set at 95.67%, which indicates a major rise in contrast to 92.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 98.74% that was higher than 74.30% volatility it exhibited in the past 100-days period.
